Co-Diagnostics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Co-Diagnostics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Co-Diagnostics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Co-Diagnostics Inc. is CODX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Co-Diagnostics Inc. has its primary listing on NASDAQ (Small cap). You can trade Co-Diagnostics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Co-Diagnostics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Co-Diagnostics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Co-Diagnostics Inc..